Apr 13, 2026
Nw operating in 20 states and Washington, D.C., Blue Circle Health is expanding free, comprehensive support for adults living with type 1 diabetes across the country.
Apr 6, 2026
The latest integration marks the first time an implantable continuous glucose monitor has been used to automate insulin delivery with a pump.
Mar 30, 2026
I spoke with Gary Scheiner, CDCES, about optimizing mealtime insulin, including bolus timing, carb ratios, and strategies to reduce post-meal spikes.
Mar 23, 2026
We break down the biggest tech stories from ATTD 2026 with endocrinologist Dr. David Ahn, exploring how fully closed loop systems, smarter sensing, and AI are reshaping the future of diabetes care.
Mar 16, 2026
A bill stalled in Congress and a promising clinical trial may together be the most important developments in type 1 diabetes treatment right now.
Mar 9, 2026
Hanne Engan shares how a routine green card interview turned into nine days in ICE detention without proper care for her type 1 diabetes.
Mar 2, 2026
I sat down with Gary Scheiner CDCES to discuss insulin variability, site failures, unexplained highs, and practical strategies to get insulin working efficiently.
Feb 23, 2026
Encapsulated neonatal pig islet cells, implanted without immunosuppression in the OPF-310 trial, cut a type 1 diabetes patient’s insulin needs in half at six months, with further maturation expected.
Feb 17, 2026
We spoke with an FDA-insider about how the organization regulates diabetes tech and how recent political events have shaken up the agency.
